tradingkey.logo

Anbio Biotechnology

NNNN
25.650USD
+1.590+6.61%
종가 02/06, 16:00ET시세는 15분 지연됩니다
1.13B시가총액
416.53P/E TTM

Anbio Biotechnology

25.650
+1.590+6.61%

자세한 내용은 Anbio Biotechnology 회사

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnology 정보

종목 코드 NNNN
회사 이름Anbio Biotechnology
상장일Feb 19, 2025
CEOLau (Michael)
직원 수27
유형Ordinary Share
회계 연도 종료Feb 19
주소Friedrich-Ebert-Anlage 49
도시FRANKFURT AM MAIN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Germany
우편 번호60308
전화4916096247281
웹사이트https://anbiobiotechnology.com/
종목 코드 NNNN
상장일Feb 19, 2025
CEOLau (Michael)

Anbio Biotechnology의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2024
FY2023
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
European Union
5.62M
68.64%
South America
1.48M
18.02%
Asia Pacific
509.17K
6.22%
Other Regions
472.38K
5.77%
North America
110.51K
1.35%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Thu, Dec 4
마지막 업데이트: Thu, Dec 4
주주
주주 유형
주주
주주
비율
Northwestern Mutual Capital, LLC
4.78%
CVC Investment
4.78%
Geode Capital Management, L.L.C.
0.06%
Marshall Wace LLP
0.02%
Morgan Stanley & Co. LLC
0.02%
기타
90.33%
주주
주주
비율
Northwestern Mutual Capital, LLC
4.78%
CVC Investment
4.78%
Geode Capital Management, L.L.C.
0.06%
Marshall Wace LLP
0.02%
Morgan Stanley & Co. LLC
0.02%
기타
90.33%
주주 유형
주주
비율
Investment Advisor
4.80%
Corporation
4.78%
Investment Advisor/Hedge Fund
0.08%
Research Firm
0.03%
Hedge Fund
0.02%
Venture Capital
0.02%
기타
90.27%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
12
2.17M
4.94%
+2.15M
2025Q3
8
2.13M
4.85%
+2.06M
2025Q2
5
4.27M
9.72%
+4.25M
2025Q1
5
4.27M
9.72%
+4.27M

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Northwestern Mutual Capital, LLC
2.10M
4.78%
+2.10M
--
Feb 19, 2025
CVC Investment
2.10M
4.78%
+2.10M
--
Feb 19, 2025
Geode Capital Management, L.L.C.
25.76K
0.06%
+8.63K
+50.40%
Sep 30, 2025
Marshall Wace LLP
10.44K
0.02%
+10.44K
--
Sep 30, 2025
Morgan Stanley & Co. LLC
8.61K
0.02%
+8.21K
+2052.50%
Sep 30, 2025
Millennium Management LLC
7.08K
0.02%
+7.08K
--
Sep 30, 2025
XTX Markets LLC
6.90K
0.02%
+6.90K
--
Sep 30, 2025
HRT Financial LP
6.01K
0.01%
+6.01K
--
Sep 30, 2025
UBS Financial Services, Inc.
960.00
0%
-9.73K
-91.02%
Sep 30, 2025
BNP Paribas Securities Corp. North America
2.42K
0.01%
+1.16K
+91.83%
Sep 30, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI